Hospital antibiotic policy in a health district

Insights

A hospital implemented a restricted antibiotic policy, significantly reducing antibiotic consumption and costs over two years. Despite some resistance, this approach prevented widespread infections and major epidemics.

Area of Science:

  • Hospital Pharmacy
  • Infectious Disease Management
  • Antimicrobial Stewardship

Background:

  • Hospital antibiotic policies are crucial for controlling antimicrobial resistance and healthcare costs.
  • Restricted antibiotic formularies can impact consumption patterns and resistance levels.
  • Previous studies highlight the need for effective strategies to manage antibiotic use in clinical settings.

Purpose of the Study:

  • To evaluate the impact of a restricted hospital antibiotic policy on antibiotic consumption, costs, and resistance.
  • To assess the occurrence of cross-infection epidemics during the policy implementation.
  • To analyze the specific antibiotics used and their associated resistance patterns.

Main Methods:

  • Implementation of a hospital-wide antibiotic policy restricting the number of prescribed agents over a two-year period.
  • Monitoring antibiotic consumption, focusing on six key antibiotics that constituted 98% of usage.
  • Surveillance of antibiotic resistance in key bacterial pathogens (Staphylococcus aureus, Enterobacteriaceae, Bacteroides) and tracking cross-infection rates.

Main Results:

  • Antibiotic consumption and total costs decreased substantially from 1976 to 1978.
  • High resistance rates to ampicillin were observed in Staphylococcus aureus (80%), Enterobacteriaceae (37%), and Bacteroides (83%).
  • No major epidemics of cross-infection were reported during the study period.

Conclusions:

  • A restricted antibiotic policy can effectively reduce antibiotic consumption and associated costs.
  • Careful selection of antibiotics within a policy can maintain clinical efficacy while managing resistance.
  • The policy demonstrated success in preventing widespread infections and controlling healthcare expenditure.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...